Part, Chapter, Paragraph
1 I, 2. 9 | the 1980s. Snow cover has decreased by 1.3 % per decade during
2 I, 2. 9 | mortality in Europe has decreased, but this could have other
3 II, 4. 2 | between 65 and 75 hardly decreased. This seems to be a temporary
4 II, 4. 2 | while the one among men decreased.~ ~Table 4.2.2. Arriaga
5 II, 4. 2 | 11 and 12 in table 3) has decreased in most countries. One remarkable
6 II, 4. 2 | mortality by traffic accidents decreased strongly for men in Greece
7 II, 5. 3. 6| in survival attributed to decreased post-operative mortality (
8 II, 5. 3. 6| where survival actually decreased. Exceptional increases in
9 II, 5. 5. 3| However, the tendency for a decreased variability in prevalence
10 II, 5. 5. 3| consistently associated with a decreased risk for Parkinson’s disease (
11 II, 5. 5. 3| associated with increased or decreased Parkinson’s disease risk,
12 II, 5. 7. 1| damage, with or without decreased GFR, as defined by~• pathologic
13 II, 5. 7. 7| al (2005) Prevalence of decreased kidney function in Chinese
14 II, 5. 8. 4| gender-related differences decreased, and COPD spread rapidly
15 II, 5. 9. 3| asthma symptoms seems to have decreased from 1995 until 2005 (-52%) (
16 II, 5. 9. 4| birth cohort studies found a decreased prevalence of allergic diseases
17 II, 5. 11. 3| aged 0–18 , nickel allergy decreased significantly from 24.8%
18 II, 5. 11. 3| sensitization was found to have decreased significantly from 36.7%
19 II, 6. 3. 3| 10 years, the incidence decreased steadily after 1996 from
20 II, 6. 3. 4| 1990s, but have similarly decreased since 2002. In Sweden and
21 II, 6. 3. 5| Latvia, and have gradually decreased over the period. In the
22 II, 6. 3. 5| of measles in Europe has decreased dramatically over the last
23 II, 6. 3. 5| Italy, but the incidence has decreased greatly in most countries
24 II, 6. 3. 6| annual incidence in Europe decreased between 1995 and 1998, but
25 II, 6. 3. 6| number of cases steadily decreased from 1999 (just under 4
26 II, 9 | slowed neurological response, decreased muscle strength and range
27 II, 9. 1. 1| foetal mortality has also decreased, but less markedly. Measuring
28 II, 9. 2. 3| 1–4 years) deaths have decreased in most European countries
29 II, 9. 3. 1| urethral atrophy, causes a decreased production of lactic acid
30 II, 9. 3. 1| depression, from frailty to decreased cognitive function, from
31 II, 9. 3. 3| partners during lifetime has decreased from 1993 to 2003 from about
32 II, 9. 3. 3| increase from 1993 to 1998, decreased again in 2003 (Weiss,2008).~ ~
33 II, 9. 3. 3| motivation in condom use and decreased perception of risk may be
34 II, 9. 4. 3| arthritis. Chronic illness and decreased mobility influences the
35 II, 9. 4. 4| slowed neurological response, decreased muscle strength and range
36 III, 10. 1. 1| motivation in condom use and decreased perception of risk may be
37 III, 10. 2. 1| passive smoking at work decreased by 10.9% (Ja ~ ~Objective
38 III, 10. 2. 1| consumed over a lifetime and a decreased volume of brain grey matter.~ ~
39 III, 10. 2. 1| of oral hygiene products decreased by an average of 0.2% annually
40 III, 10. 2. 1| women and the likelihood decreased with age.~ ~Figure 10.2.
41 III, 10. 2. 1| 39.4% in 1997, but then decreased to 36.8% in 2002 (Lamprecht
42 III, 10. 2. 1| resistance to infections and decreased work performance. Causes
43 III, 10. 2. 1| of local production has decreased with improvements in food
44 III, 10. 3. 4| certain~Reduced mortality from decreased cold exposure~Increase in
45 III, 10. 5. 1| from respiratory causes decreased by 15.5% and deaths from
46 III, 10. 5. 1| from cardiovascular causes decreased by 10.3% (Clancy et al,
47 III, 10. 5. 2| rates in rural areas and decreased mortality rates in urban
48 IV, 11. 1. 6| referrals to specialists decreased as GPs were taking on more
49 IV, 11. 2. 1| stay in hospitals has also decreased substantially in recent
